Physician profile
Jayson Eric Gesme
NPI 1821042698
$2,404.14
in general payments reported to CMS, 2019-2025
10 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2022: $74.01 · 2023: $69.21 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,741 · Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,741.04 |
| Food and Beverage | $423.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $2,045.59 | 2025 | Gelpoint Advanced Access Platform |
| Stryker Corporation | $148.85 | 2019 | |
| Hologic INC | $56.23 | 2022 | |
| Tersera Therapeutics LLC | $31.97 | 2025 | Zoladex |
| Daiichi Sankyo INC. | $24.67 | 2023 | Enhertu |
| Hologic Sales and Service, LLC | $23.31 | 2023 | Localizer |
| Bard Peripheral Vascular, INC. | $21.23 | 2023 | Bard Marquee |
| Elucent Medical | $18.23 | 2025 | |
| Smith+Nephew, INC. | $17.78 | 2022 | |
| Covidien LP | $16.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayson Gesme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.